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The ruthenium complex [Ru(phen)2(dppz)]2+ (where phen is a phenanthroline and dppz 
a dipyridyl–phenazine ligand) is known as a ‘light-switch’ complex because its 
luminescence in solution is significantly enhanced in the presence of DNA. This 
property is poised to serve diagnostic and therapeutic applications, but its binding mode 
with DNA needs to be further elucidated. Here we describe the crystal structures of   the 
Λ enantiomer bound to two oligonucleotide duplexes. The dppz ligand intercalates 
symmetrically and perpendicularly from the minor groove of the d(CCGGTACCGG)2 
duplex at the central TA/TA step — but not at the central AT/AT step of 
d(CCGGATCCGG)2. In both structures, however, a second ruthenium complex links 
the duplexes by a combination of a shallower angled intercalation into the C1C2/G9G10 
step at the end of the duplex, and semi-intercalation into the G3G4 step of an adjacent 
duplex. The TA/TA specificity of the perpendicular intercalation arises from the 
packing of phenanthroline ligands against the adenosine residue.  
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The binding of small molecules to DNA is key in understanding the mode of action of many 
drugs, and increasingly useful too in nanotechnological applications of nucleic acids. 
Intercalation as a binding mode was described by Lerman in his pioneering studies, based on 
observations with acridine (10-aza-anthracene) derivatives, and using fluorescence and 
dichroic methods1.   
Crystallographic studies2-6 later showed that the acridine chromophore was indeed 
intercalated between base pairs of the B-DNA double helix, in parallel fashion, that is with 
the long axis of the acridine molecule parallel to those of the base-pair. This is accompanied 
by significant local unwinding of B-DNA; the helix is typically lengthened by about 3.4 Å.   
Further structural studies have shown that a variety of intercalation geometries is possible 
with different chromophores, for example parallel, perpendicular, or — as we report here — 
angled.   
Several of these reports deal with molecules which are clinically important anticancer agents, 
such as the anthracycline antitumour antibiotic daunomycin7, used in the treatment of 
leukaemias. The polypeptide antibiotic actinomycin D8 inhibits both DNA and RNA 
synthesis by blocking chain elongation.  These species, however, often have bulky 
functionalised substituents on the central heteroaromatic portion of the molecule, which 
undergo specific interactions in the grooves of the DNA, and might therefore have a 
determining role on the orientation of the molecule. For many other molecules,  studies of 
intercalation are based on biophysical and spectroscopic studies in solution9, which 
demonstrate, as expected, an orientation of the intercalated chromophore, helix lengthening,  
overall unwinding (in most cases, and as distinct from local twist angle), as well as the 
anticipated shifts in the positions of spectroscopic features of the intercalated molecule.  
Although nuclear Overhauser effect nuclear magnetic resonance (NOE NMR) studies have 
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been possible in a few cases10, structural models of intercalation from NMR data alone are 
rare11.   
Because of their potential as biosensors and therapeutic agents, there has been very 
considerable interest in metal complexes where one of the ligands can intercalate between the 
base pairs of DNA, and the area has been reviewed recently12-14. Octahedral complexes with 
a dipyridophenazine (dppz) ligand have been particularly intensively studied, because of the 
so-called‘light-switch’effect. These complex cations show no photoluminescence in water at 
ambient temperatures, but display intense photoluminescence when added to solutions of calf 
thymus and synthetic DNAs. The luminescence is also seen in non-aqueous solutions, leading 
to the assumption that the key property is the exclusion of water from the chromophore in 
DNA.  These unusual photophysical properties15,16 make them suitable as DNA light-
switching sensors17,18, as agents to target photo-oxidation in DNA19,20 and as probes for DNA 
conductivity21.  it is known from spectroscopic and biophysical methods that the dppz ligand 
is intercalated between the base-pairs of the polynucleotide22-24 but so far no definitive 
evidence for any binding site for 1 had been available.   
We have now carried out the crystallographic study of a complex between Λ-
[Ru(phen)2(dppz)]2+ (1) and an oligonucleotide. Here we describe the specific perpendicular, 
symmetrical, classical intercalation mode we observed for the dppz ligand of (1) at the 
TA/TA central step of  a d(CCGGTACCGG)2 duplex.  We contrast this with the lack of such 
binding at the AT/AT central step of the d(CCGGATCCGG)2 duplex, which differs only in 
the switch  from TA to AT at the central step. With both sequences, we also observe a second 
metal complex intercalated with the oligonucleotide for which, in contrast to previous 
studies, the intercalation of dppz at the terminal GG/CC step that occurs is angled (neither 
parallel nor perpendicular with the base pairs). The angle also enables another interaction, not 
observed previously, to take place: the semi-intercalation of phen (1,10 phenanthroline) at the 
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G3G4/C7C8 step — similar to that  observed for Λ-[Ru(TAP)2(dppz)]2+ (2) with the 
d(TCGGCGCCGA)2 duplex25. There is a minor end-effect of a syn-guanine at G10, but 
otherwise, this work provides striking confirmation in the solid state of the evidence already 
gathered in solution for more than one type of binding site26, and may explain the presence of 
two fluorescence decay lifetimes found for 1 bound to DNA in solution, even for single 
enantiomers and non-alternating double-stranded homopolymers.   
 
1       2 
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Results 
Crystallisation, measurement and structure solution.   Racemic [Ru(phen)2(dppz)]Cl2 and 
a decamer — either d(CCGGTACCGG)20-21 or d(CCGGATCCGG)22 — in a buffer  
containing spermine, 2-methyl-2,4-pentanediol, sodium cacodylate pH 7.0, NaCl and BaCl2 
were allowed to stand in the dark, at 20°C for d(CCGGTACCGG) and 4°C for 
d(CCGGATCCGG).  Crystals formed after a few days, as orange rhombs.  The crystals were 
flash-frozen, and their structure subsequently characterized by X-ray crystallography (data 
measured at 100 K).  Full details of the data collection and refinement statistics are given in 
the Methods section and Supplementary Information (Text T1 and T2, Tables S1 and S2).  
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Figure 1 | Crystallisation of the ruthenium cation Λ-[Ru(phen)2(dppz)]2+and 
oligonucleotides.  (a) Packing diagrams of the two structures projected down the c axial 
direction, to highlight the symmetrical intercalation of Ru2 at the T5A6/T5A6 step in the 
d(CCGGTACCGG)2   duplex (above) compared with the d(CCGGATCCGG)2 duplex (below). 
Ru2 shown space-filling in purple, Ru1 shown ball-and-stick in purple. (b) Conformation of a 
single strand of the decamer d(CCGGTACCGG), with the base numbering. The disordered 
C1 is shown in the two main conformations (each 0.3 occupancy). Note the syn conformation 
of guanine residue G10. Colour code for bases is cytosine: magenta, guanine: green, 
thymine: cyan, adenine : red. The DNA backbone, bases and sugars are shown in cartoon 
mode in grey. (c) Location of the ruthenium cations in the asymmetric unit of the single 
strand. Ru 1 in dark blue, Ru2 in purple, both in spacefilling mode,  DNA backbone 
(connecting P positions) orange, carbon: green, oxygen: red, nitrogen: blue, all in cartoon 
mode. The central Ru2 cation is treated as a whole complex of 0.5 occupancy per 
oligonucleotide strand, and the view direction is down the crystallographic twofold axis into 
the minor groove (d) The final electron density map at the T5A6/T5A6 step of 
d(CCGGTACCGG)2, showing the intercalated ruthenium complex Ru2, drawn in stick mode. 
Map drawn, in grey, at the 1.0 sigma contour level.  Nucleic acid strands in stick mode, 
phosphorus: orange. 
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Figure 2 | The assembly of the duplexes. (a) The twofold rotation axis generates the 
complete d(CCGGTACCGG)2 duplex with three bound cations; compare Figure 1c. Ru1 in 
dark blue, Ru2 in purple, both in spacefilling mode,  DNA backbone (connecting P positions) 
orange, carbon: green, oxygen: red, nitrogen: blue, all in cartoon mode. The central Ru2 
cation is treated as a whole complex of 0.5 occupancy per oligonucleotide strand, and the 
view direction is down the crystallographic twofold axis into the minor groove.  (b) The same 
duplex with the addition of the semiintercalated cations (shown in paler blue) from 
symmetry-related duplexes, (c) the same assembly rotated through 90° about the vertical 
helix axis. The twofold rotation axis is now in the horizontal direction As throughout (except 
from Fig 1), the two strands of each duplex are coloured green and cyan for clarity, but all 
are crystallographically equivalent. 
(d)-(f) The corresponding duplex (note the wider groove), containing only intercalated Ru1 
(dark blue) and semiintercalated Ru1 (light blue). View directions and colour codes are the 
same. 
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Description of the structures  
Complex between 1 and d(CCGGTACCGG)  
This self-complementary sequence crystallizes to give a symmetrical duplex with a 
stoichiometry of three cations of 1 per duplex, or 1.5 cations of 1 per decamer strand. All the 
nucleic acid strands are equivalent in the crystal lattice, with the packing shown in Figure 1a. 
The conformation of a single resulting oligomer strand is shown in Figure 1b, showing the 
numbering scheme, and in 1c to show the ligand binding sites. This structure is quite different 
from that found for d(CCGGTACCGG) itself, which has previously been the study of 
detailed study27, 28 because it spontaneously crystallises as the DNA Holliday junction in the 
presence of Group II metal cations29. The quality of the experimental map is shown in Figure 
1d with a view of 1 from the minor groove of the duplex. 
Two ruthenium cations (Ru1) are symmetrically equivalent, related by the twofold axis 
running through the centre of the duplex, with a third cation (Ru2) lying on the same axis and 
being bound at the central step of the duplex (T5A6/T5A6). The ruthenium atoms lie in the 
minor groove of the duplex, with a hydrated barium cation in the major groove. There is a 
large solvent channel, so that the intercalated dppz ligand is embedded within the DNA base 
stack, while the phen ligands remain solvent-accessible in the minor groove. The asymmetric 
unit and overall assembly with the bound ruthenium complexes are shown in two orientations 
in Figure 2. Panels (a)-(c) depict the d(CCGGTACCGG)2 duplex, to show the different 
locations of angled intercalation (C1C2/G9G10), symmetrical perpendicular intercalation 
(T5A6/T5A6), and semiintercalation (G3G4/C6C7).  
The specificity of this symmetrical intercalation for the lambda enantiomer of 1 is striking. 
We wondered if by reversing the central step sequence, we might see an equally specific 
interaction of the delta enantiomer. We therefore decided to try crystallizing a sequence with 
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the central step reversed but, again, using the racemic complex in the crystallization 
conditions, making no assumptions about the binding of the lambda and delta enantiomers. 
 
Complex between 1 and d(CCGGATCCGG) 
The above self-complementary sequence crystallizes to give a symmetrical duplex with only 
two cations of 1 per duplex, or one per decamer strand, with all strands being equivalent in 
the crystal lattice. Previous studies have shown that this sequence crystallizes as the duplex29 
in the absence of the ruthenium complex. The key difference between this structure and the 
TA containing model is that there is no complex bound at the central step (A5T6/A5T6), and 
the geometry of the central step (A5T6/A5T6) is consistent with B-DNA (Figure 2). Panels (d)-
(f) show the corresponding d(CCGGATCCGG)2 duplex, showing the absence of the 
symmetrical intercalation mode here. The groove width at the central step can be seen to be 
narrowed by intercalation, by comparing the two backbone conformations. The P-P distance 
across the central step is 18.5 Å in (d), compared to 15.6 Å in (a). 
 
Intercalation site T5A6/T5A6 and Ru1 geometry in d(CCGGTACCGG)2. This is the first 
direct observation of a symmetrical perpendicular intercalation by the dppz ligand in an 
octahedral metal complex (Figure 3).  The dppz is deeply inserted so that the ruthenium atom 
is only about 5 Å from the helix axis. Although the duplex has an overall curvature caused by 
the semiintercalation at the G3G4 step, there is no curvature at this intercalation site. The 
other distinctive feature of this intercalation geometry is the high local basepair step twist, of 
nearly 40°. The deep insertion is central to the observed specificity of the intercalation (see 
Discussion), and a particularly important consequence of the intercalation geometry at this 
step is that the phen ligands are then unable to semiintercalate into a second duplex. A further 
consequence of this deep intercalation is that the dppz ligand protrudes from the base stack 
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into the hydrated major groove. A simple way to compare this symmetrical geometry with the 
angled geometry, to be described in the next section, is the use of a P-Ru-P triangle (Figure 
3b). In this symmetrical geometry, both Ru-P distances are about 8.3 Å, with the P-P 
separation distinctively short at 15.6 Å, and correlating with the high twist. The buckle at this 
step is 17°, with an opening of 7.3° and a propeller twist of 13.2° to accommodate the dppz 
chromophore, and maintaining a B-DNA conformation at these residues. The two hydrogen 
bonds at this step, giving a T5(O4)-A6(N6) distance of 2.97 Å, and a T5(N3)-A6(N1) distance 
of 2.86 Å, are close to normal values.   
Figure 3. The symmetrical perpendicular intercalation geometry at the central TA/TA step. 
(a) The Ru2 complex, shown in purple, intercalated between the T5-A6 basepairs. The 
twofold rotation axis runs vertically down the middle, so that the view from the other side is 
identical, although the two strands are coloured in green and cyan for clarity.  The T5-A6 
hydrogen bonds are shown by yellow dashes. The phenanthroline ring contacts the adenine 
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H2 (on C2) and H4’ (on C4’ of the deoxyribose) as shown by rendering just these two 
hydrogen atoms in yellow space-filling mode. (b) The use of a P-Ru-P triangle to define the 
intercalation geometry, using the same projection as in a). The P-P distance is short, at 15.6 
Å, and the two Ru-P distances are 8.3 Å. Ruthenium atom in teal, phosphorus atoms in 
orange (c) View down the twofold axis from the minor groove side. In this orientation it is 
clear that the symmetrical orientation is maintained by the four contacts highlighted in a). (d) 
A sideways view, to show the extent of exposure of the dppz ligand in this symmetrical 
orientation. Note the projection of the dppz ligand into the major groove, also evident in (a).  
13 
 
 
 
Terminal intercalation site G9G10/C1C2. Both these structures contain a second ruthenium 
cation, Ru1, bound by intercalation from the minor groove at the ends of the decamer duplex 
(Figure 4). This is a GG/CC site, and has the same geometry in both structures. Notably, only 
the guanine side of the base pair interacts fully with the complex, although both basepairs are 
complete. The terminal guanosine has adopted a syn-conformation, perhaps to maximise the 
stacking interaction between the purine ring and the dppz ligand, and giving a Hoogsteen-
type base pairing. (Figure 4b).  Although the C1 cytosine is only partly ordered, there remains 
a single hydrogen bond to this syn guanine G10.  In this cavity, the ruthenium atom is about 6 
Å from the helix axis, with the purine six-membered ring stacking onto the pyrazine ring of 
the dppz chromophore (Figure 4a). It appears that the guanine 2-NH2 substituent limits the 
depth to which the dppz can intercalate, making for the shallower intercalation. The angled 
geometry shown in Figure 4c can be contrasted with the symmetrical geometry of Figure 3b, 
and here, the closest Ru-P distance is 7.9 Å. 
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Figure 4 | The CC/GG angled intercalation geometry.(a) The C2-G9 basepair, showing the 
stacking between the six-membered ring of the purine base and the pyrazine ring of the dppz 
ligand. The contacts between the phenanthroline ligand and residue C2 are highlighted as 
H1’ and H4’ of the deoxyribose, rendering the hydrogen atoms only as yellow spheres. H2a 
of the G9 residue (the 2-amino substituent unique to guanine) is similarly highlighted. These 
contacts define the phen orientation, and the angled geometry, leaving the other phen ligand 
free, and in this lattice it semiintercalates into a symmetry-related duplex at the G3-G4 step, 
in the direction of the arrow; (b) the view from the other side, in this case different, and 
showing the C1-G10 step. The combination of disordered cytosine and syn-guanine mean that 
this is not a standard basepair (closer to Hoogsteen-type) and probably should not be 
regarded as having the same influence on ligand orientation as the very well defined C2-G9 
step. The arrow again shows the direction of the semiintercalated interaction with the 
symmetry-related duplex; (c) the angled geometry as a P-Ru-P triangle. The shorter Ru-P 
distance is here 7.9 Å, the longer one 10.9 Å, with a P-P separation of 16.9 Å (compare the 
very short P-P separation in Figure 3) 
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The GG/CC semiintercalation site. The angled intercalation mode, seen with both 
d(CCGGTACCGG)2 and d(CCGGATCCGG)2, creates asymmetry with respect to the 
phenanthroline interactions, one forming several close contacts, while the other is free, as 
shown by the arrow in Figure 4. A feature of the packing seen here is that this free phen is 
able to semiintercalate into a second duplex at the G3-G4 step in both structures (Figure 5a 
and b). This phen ligand forms a series of close contacts within the semiintercalation cavity, 
as highlighted by the yellow spheres of Figure 5a, and it is not possible to single out one 
specific interaction. A comparable finding was the highlight of our earlier study of the 
d(TCGGCGCCGA)2 duplex bound to 225, with semiintercalation of the TAP chromophore. 
In that work, we were unable to obtain any crystals with phen, so it is important to emphasise 
that semiintercalation, well known from solution studies, but not previously from 
crystallography, has now been seen for the phen ligand also. The crosslinking of two 
duplexes which results, and which generates the overall packing of Figure 1, is shown in 
Figure 5c, which shows all the contacts made by a single angled ruthenium cation in this 
enantiospecific packing. The geometry at this step is close to that previously observed, with 
the proviso that there is a closer stacking of the phen chromophore onto the G4 purine ring, 
with the angle between the G3 purine plane and the phen plane opened up to 43°. It is this 
step which causes the overall curved appearance of the bound duplex, in fact due to the sharp 
kink at this point. The kink also creates a favourable binding site for the barium ion, which is 
coordinated to G3, G4 and T5, as well as five water molecules, in a curved but strongly 
hydrated major groove (Supplementary Figure S2). 
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Figure 5 | Semiintercalation of one phenanthroline ligand.  (a) Semiintercalation into the 
G3G4/C6C7 step of the d(CCGGATCCGG)2 duplex. There is no single short contact; rather, 
the phen surface highlighted by colouring the hydrogens yellow contacts the surfaces of the 
two purine rings at G3 and G4 on either side. (b) the semiintercalation geometry represented 
as a P-Ru-P triangle for comparison with Figures 3b and 4c. The shorter Ru-P distance is 
10.2 Å (to C8-P) and the longer one (to G4-P) is 11.4 Å, with the P-P spacing lengthened to 
18.8 Å. The dppz ligand is on the right. (c) the overall environment of the ruthenium cation 1 
both intercalated and semiintercalated into two duplexes of d(CCGGATCCGG)2.  
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Discussion 
This work provides the first structural evidence that the DNA ‘light-switch’ complex 1 binds 
to an oligonucleotide by both symmetrical (perpendicular, or ‘head-on’), and by angled 
(canted) intercalation modes, and in each case through the minor groove of B-DNA. Angled 
intercalation is here combined with semiintercalation of one phen ligand. 
The symmetrical dppz intercalation mode seen at the central TA/TA step leaves the helix 
straight, the ruthenium atom close to 5 Å from the helix axis, and as B-DNA, with only minor 
buckling of the TA basepairs.  The enantiomeric and step specificity of this intercalation 
geometry is striking. Figure 3 provides a possible starting point to understand the structural 
features which may be responsible.  What we see is that the phen ligands pack orthogonally 
directly against the adenosine residue, with the closest contact the H4’ of the sugar ring, 
making the two closest contacts this H4’ and the adenine 2C-H. These two hydrogens are 
shown as yellow spheres in Figure 3, which, by virtue of the symmetry is actually four such 
contacts. Figure 3a shows that they occupy strategic locations at either end of the phen 
ligand.  The overall geometry and high twist angle at this site appear to be dictated by these 
two contacts, and it is possible that a weak attraction between the phenanthroline system and 
the ribose hydrogen H4’ is responsible for the high twist. These observed contacts, to the 
adenine 2C-H and to the C4'-H of ribose, contrast the rigidity of the phenanthroline with the 
flexibility of the TA/TA step. This flexibility is also highlighted by the unusually short P-P 
separation of 15.6 A, compared to  16.9 Å at the angled intercalation site, 18.8 Å at the 
semiintercalation site, and 18.5 Å at the corresponding unbound AT/AT step.  The result is a 
deep symmetrical intercalation, specific to the TA/TA step.   
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In contrast, the angled shallower intercalation seen at the terminal G9-C2/G10-C1 step shows 
that the helix axis (the centre of the basepair) is displaced, to the rim of the dppz 
chromophore. This asymmetry can again be contrasted with the symmetrical location of the 
axis seen with the T5A6/T5A6 basepair. Additionally, the twist angle between the basepairs is 
only 26°, compared to the 41° seen at the T5A6/T5A6 step. These differences are also seen in 
the P-Ru-P triangle (Figure 4c), which highlights the asymmetry of this angled intercalation, 
exposing one face of the dppz ligand to solvent but enclosing the other. The shorter Ru-P 
distance is now only 7.9 Å. This geometry permits the semiintercalation of a phen ligand into 
the minor groove of a G3G4/C7C8 step of a symmetry related duplex. This noncovalent 
crosslinking is only possible because of the shallow intercalation, lower twist, and purine 
stacking at this step. In turn, this is a selectivity which is only possible because intercalation 
is from the minor groove side. From the major groove, guanine and adenine are sterically 
very similar. This form of base selectivity has been studied at length for minor groove 
binding molecules, but to the best of our knowledge has not been seen for well characterised 
intercalative binding. An examination of the phen-nucleotide contacts reveals that, as with 
the symmetrical intercalation, there are contacts between the ribose ring and the phen ligand. 
These short contacts are shown in Figure 4a and b.   
Important comparisons can be made with Actinomycin D and daunomycin, both of which 
also intercalate from the minor groove.  In many literature examples30, the nucleic acid 
duplex is formed from a hexanucleotide or smaller, with intercalation at the terminal steps.  
Actinomycin D is the best example of minor groove intercalation into a non-terminal site, but 
differs in generating an A-DNA conformation, in showing parallel intercalation of the 
chromophore at a GC/GC step, and forming a range of specific minor groove interactions. 
The twist angles here are correspondingly very low. The perpendicularly bound daunomycin 
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family has also been the subject of many studies, all of which show minor groove binding to 
a terminal CG step of a symmetrical hexameric duplex, with a twist of about 36° in all the 
examples.  The symmetrical intercalation mode of 1 is at one end of the known range, 
combines high twist, low P-P separation and deep perpendicular intercalation. In contrast, the 
intercalation of Δ-[Rh(bpy)2chrysi)]+ (chrysi= chrysene-5,6-quinone diimine) into a TA/TA 
step from the major groove gave a similar M-helix axis distance as found for 1, both about 5 
Å, but this example has a twist angle of less than 31°, with no interaction between the bipy 
ligands and the DNA duplex31.   
 
Figure 6 | The relationship between intercalation geometry – parallel, perpendicular or 
angled chromophore, and the P-P separation across the cavity. The symmetrical 
intercalation in this work gives rise to the highest known local twist and the closest known P-
P separation. No other data on angled intercalation is available. Green – perpendicular 
intercalation, red – parallel intercalation, purple – angled intercalation. Data are plotted for 
daunomycin7, Actinomycin D 8, [Rh(bpy)2(chrysi)]+31, nogalamycin32,  an acridine-4-
carboxamide derivative 4, and ethidium2.  There are two points for Actinomycin D (PDB code 
1MNV) which occupies the low twist/parallel intercalation extreme, associated with the many 
specific minor groove interactions. For determination of the twist angles in this work, see the 
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Supplementary Information. Our survey of Nucleic Acid Database entries for intercalation, 
from which these examples are selected, is included as Supplementary Information, Dataset 
1. 
Although there are clear parallels with daunomycin with respect to chromophore orientation, 
a striking difference is in the origin of the high binding constant of 1 with natural DNA24. 
The daunomycin molecule can interact with DNA in many more diverse ways than 1, and in 
the crystal structure forms two specific short hydrogen bonds to an adjacent guanine base, 
along with several specific hydrogen bonds to surrounding water molecules. Each of these 
contributes to the overall energetic, dominated by the favourable enthalpy term. In contrast, 
the ruthenium complex 1 intercalates without the formation of any specific bonding 
interaction with either DNA or water other than π-stacking of the dppz ligand. Thus the 
intercalation releases both bound water and cations from the oligonucleotide, particularly in 
the minor groove. In this groove the phen ligands displace all the ordered water.  
The origin of the ‘light-switch’ phenomenon has been the subject of many 
investigations17,18,24,25, and detailed photophysical measurements33-35  have shown that this is 
due to the formation of a dark state in aqueous solution, and emission from the bright state 
when bound to DNA.  Another feature arising from time-resolved emission studies of the 
complexes when bound to DNA is the presence of two quite distinct emission lifetimes.  The 
use of enantiopure complexes and homogeneous polynucleotides ruled out sequence 
heterogeneity as the cause, although it was found that the proportion of the two lifetimes was 
very sensitive to the ‘loading’ of the complex on the polynucleotide25.  Two main proposals 
which have been made are (i) different orientations within the major groove22 or (ii) isolated 
or contiguous binding in the minor groove18. Neither of these proposals is consistent with our 
observations. Recent work in the Lincoln laboratory points to an alternative explanation – 
namely cooperative and anti-cooperative interactions36 in the minor groove as being the 
origin of the two lifetimes, with the data only being fittable on the assumption that there are 
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two orientations in the intercalation pocket, with the shorter lifetime arising from the 
symmetric perpendicular intercalation mode we see for the first time here.  The rationale for 
this interpretation would be that only one of the un-coordinated dppz nitrogen atoms can 
form a hydrogen bond to a solvent water molecule in an angled intercalation, but that both 
can do so in a symmetrical intercalation. As we accumulate crystallographic data on these 
complexes, we believe that we will be able to carry out a detailed analysis of bound water, 
which is likely to depend on the ligands employed in the study. 
In summary, this study reports two distinct modes of intercalation of the DNA-light-
switching complex [Ru(phen)2(dppz)]2+.  It also demonstrates that the intercalation proceeds 
with changes in the DNA conformation,  which are similar to those found in the crystal 
structure of certain classical DNA intercalators (e.g. daunomycin) but different from others 
(e.g. actinomycin D),   and  illustrates that there is still much to learn about the detailed 
geometrical requirements of DNA intercalation. The prevailing view of intercalation in the 
wider literature is often coloured by the predominance of parallel intercalation geometries in 
the early work. We have observed two intercalation modes, neither of which fit the parallel 
pattern:  symmetric (perpendicular) and angled (canted), clearly distinguished by both 
sequence preference and by well-defined geometric criteria, and which correlate with the best 
solution data. The unambiguous observation of both these interactions significantly 
contributes to our understanding of this important class of synthetic intercalators. 
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Methods 
Preparation and Analysis of Crystals Containing CCGGTACCGG 
Crystals containing d(CCGGTACCGG)2 were grown by vapour diffusion, from sitting 
drops, at 276 K. A crystal of approximate dimensions 30x30x30 µm was mounted on a 
MicroMesh (MiTeGen) and data were collected on I04 at Diamond Light Source Ltd. Data 
were processed using xia237, with XDS (X-ray Detector Software)38 and SCALA (continuous 
scaling program)39, giving 2908 unique reflections with a resolution of 2.10 Å. Initial model 
building was performed using Coot (Crystallographic Object-Oriented Toolkit)40 and the 
model was refined using REFMAC5.6 (maximum likelihood refinement) 41 from the CCP4 
(Collaborative Computational Program 4) 42 suite. Five percent of reflections were used for 
the Rfree test. The model gave a final Rcryst of 0.17 and Rfree of 0.23. The structure, along with 
experimental data, are deposited in the Protein Data Bank with ID 3U38. For data collection 
and refinement statistics and full experimental details, including initial phasing with the 
maximum likelihood phasing programs SHELXC/D/E43; see SI Text T1. 
Preparation and Analysis of Crystals Containing CCGGATCCGG 
Crystals containing d(CCGGATCCGG)2 were grown by vapour diffusion, from sitting drops, 
at 276 K. A crystal of approximate dimensions 200x200x100 µm was mounted on a 
MicroMesh (MiTeGen) and data were collected on I02 at Diamond Light Source Ltd. Data 
were processed using xia237, with XDS38 and SCALA39, giving 4747 unique reflections with 
a resolution of 1.70 Å. Initial model building was performed using Coot40 and the model was 
refined using REFMAC5.641 from the CCP442 suite. Five percent of reflections were used for 
the Rfree test. The model gave a final Rcryst of 0.15 and Rfree of 0.18. The structure, along with 
experimental data, are deposited in the Protein Data Bank with ID 4E95. For data collection 
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and refinement statistics and full experimental details, including initial phasing with 
SHELXC/D/E43; see SI Text T2. 
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TOC legend (suggested) 
DNA sensing and photodynamic therapy require specific recognition. Three binding modes 
of a ruthenium ‘light-switch’ complex with DNA are here seen by X-ray crystallography. The 
deep symmetric intercalation from the minor groove at the TA/TA step is now thought to 
correspond to the shorter of two photochemical lifetimes. 
